Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H-Source is a healthcare technology company that operates a member-based SaaS marketplace for hospitals, surgery centers, and other medical entities to buy, sell, and transfer medical products and equipment. Its platform focuses on capital equipment, medical devices, pharmaceuticals, and related supply-chain workflows, with features spanning marketplace transactions, ERP integrations, asset management, reporting, pricing analytics, and warehouse management. The company also promotes blockchain-enabled chain-of-custody tracking aligned with GS1, FDA DSCSA, and UDI/GTIN requirements for drugs and devices. H-Source appears to generate revenue from commercial software and transaction services rather than from developing therapeutic products. For a biotech analyst, it is best classified as a healthcare supply-chain and marketplace software company rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H-Source.